(a) Ribo-Keima reporter cells were treated with BafA (50 nM, 1h),
Torin1 (150 nM, 24h), or combination of the two, then analyzed by
flow-cytometry. Frequency distributions of 561/488 nm excitation ratios are
shown (n = 10,000 cells per condition).
(b) The mean value of the biological triplicate experiments for
561/488 nm excitation ratios (from panel b) is shown in the histogram. Error
bars represent S.E.M. (****p
<0.0001, **p <0.01,
*p <0.04, Two-way ANOVA). (c)
Ribo-Keima reporter cell lines treated with Torin1 (150 nM, 24h), SAR405 (an
inhibitor of VPS34, 1 μM, 24h), or combination of the two were
immunoblotted for Keima and LC3B. (For asterisk, see Supplemental Fig. 1d)
(d) Confocal images of live HEK293 cells expressing RPS3-Keima
after Torin1 (150 nM, 24h) or Torin1 (150 nM, 24h)/SAR405 (1 μM, 24h)
co-treatment. (Scale bar = 20 μm) (e) Unbiased
quantitation of the live-cell images in panel d for number of red Keima puncta
per cell are shown. Mean ± S.E.M. (n=52, 60, 60 cells from three
independent experiments) (f) HEK293 RPS3-Keima cells stably
expressing LAMP1-eGFP were incubated in the presence or absence of Torin1 for
24h prior to live-cell imaging. (Scale bar = 20 μm)
(g) HEK293 RPS3-Keima cells treated as in (f) were stained with
LysoTracker Green prior to live-cell fluorescence microscopy. (Scale bar
= 20 μm) (h) HEK293 RPS3-Keima cells stably
expressing eGFP-LC3 were treated as in (f), then subjected to live-cell
fluorescence microscopy. (Scale bar = 20 μm) For panels f-h,
co-occurrence (%) of red Keima puncta with LAMP1-eGFP
(n > 1800 puncta), LysoTracker Green
(n > 2000 puncta), and eGFP-LC3 n
> 110 puncta) were calculated and plotted as black bars. Random
co-occurrence (%) is shown as white bars (see METHODS). Mean ±
S.E.M. (****p < 0.0001,
***p < 0.001,
**p < 0.01, Two-way ANOVA)
Statistical source data for b, f, g, h can be found in Supplementary Table 2.
All experiments were performed three times with similar results. Unprocessed
original scans of blots are shown in Supplemental Fig. 6.